Split History
ETFs Holding CYT »    CYT Historical Stock Prices »

Video: What is a Stock Split?

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Cyteir Therapeutics is a clinical-stage biotechnology company focused on developing and commercializing the oncology medicines that inhibit deoxyribonucleic acid damage repair and cause cancer cell death in specific subsets of cancer patients through a therapeutic strategy known as synthetic lethality. Co.'s primary program, CYT-0851, was identified through a phenotypic screening strategy that exploited a synthetic lethality between cytidine deaminases (CD) overexpression and homologous recombination inhibition. The screen was designed to select for compounds that induced synthetic lethality in CD-overexpressing cancer cells while sparing normal cells. According to our CYT split history records, Cyteir Therapeutics has had 2 splits.
CYT split history picture
Cyteir Therapeutics (CYT) has 2 splits in our CYT split history database. The first split for CYT took place on July 24, 1996. This was a 3 for 1 split, meaning for each share of CYT owned pre-split, the shareholder now owned 3 shares. For example, a 1000 share position pre-split, became a 3000 share position following the split. CYT's second split took place on September 18, 2014. This was a 2 for 1 split, meaning for each share of CYT owned pre-split, the shareholder now owned 2 shares. For example, a 3000 share position pre-split, became a 6000 share position following the split.

When a company such as Cyteir Therapeutics splits its shares, the market capitalization before and after the split takes place remains stable, meaning the shareholder now owns more shares but each are valued at a lower price per share. Often, however, a lower priced stock on a per-share basis can attract a wider range of buyers. If that increased demand causes the share price to appreciate, then the total market capitalization rises post-split. This does not always happen, however, often depending on the underlying fundamentals of the business.

Looking at the CYT split history from start to finish, an original position size of 1000 shares would have turned into 6000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Cyteir Therapeutics shares, starting with a $10,000 purchase of CYT, presented on a split-history-adjusted basis factoring in the complete CYT split history. CYT split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 06/18/2021
End date: 03/15/2024
Start price/share: $17.40
End price/share: $3.02
Dividends collected/share: $0.00
Total return: -82.64%
Average Annual Total Return: -47.19%
Starting investment: $10,000.00
Ending investment: $1,736.04
Years: 2.74
Date Ratio
07/24/19963 for 1
09/18/20142 for 1
CYT is categorized under the Materials sector; below are some other companies in the same sector that also have a history of stock splits:

CZN Split History
DD Split History
DNA Split History
DNN Split History
DOW Split History
DSWL Split History
DWDP Split History
EAG Split History
ECL Split History
ECO Split History

Email EnvelopeFree CYT Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

Crown Electrokinetics Corp. (CRKN)
Medalist Diversified REIT, Inc. (MDRR)
Medalist Diversified REIT, Inc. (MDRR)
Qilian International Holding Group Limited (QLI)
Bluejay Diagnostics, Inc. (BJDX)
Atara Biotherapeutics, Inc. (ATRA)
GRI Bio, Inc. (GRI)
Williams-Sonoma, Inc. (WSM)
Workhorse Group Inc. (WKHS)
Virgin Galactic Holdings, Inc. (SPCE)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

CYT Insider Buying

CYT Split History | www.SplitHistory.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
Wait! Don't leave yet.
Want to receive our latest research absolutely free?

Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.